ID

12122

Description

Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels; ODM derived from: https://clinicaltrials.gov/show/NCT02375828

Link

https://clinicaltrials.gov/show/NCT02375828

Keywords

  1. 9/25/15 9/25/15 - Julian Varghese
Uploaded on

September 25, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828

Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age below 18 years
Description

age below 18 years

Data type

boolean

Alias
UMLS CUI [1]
C0001779
neonatal diabetes secondary to documented mutation in one of the 2 sub units of potassium channels
Description

Neonatal diabetes mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0158981
patients already treated by glibenclamide pills
Description

glibenclamide; treated by

Data type

boolean

Alias
UMLS CUI [1]
C0017628
signed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
families unable to fill in the questionnaries
Description

unable to fill in the questionnaries

Data type

boolean

Alias
UMLS CUI [1,1]
C3273494
UMLS CUI [1,2]
C3714738
patients unable to answer to the visual hedonic squale
Description

unable to answer to the visual hedonic squale

Data type

boolean

patients unable to take the oral solution
Description

unable to take the oral solution

Data type

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C1720654
known allergy to sulfonylureas or to other antidiabetic or antibiotic sulfamides
Description

antibiotic; other; allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0038766
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0935929
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0038703
insulin therapy associated to glibenclamide
Description

insulin therapy; glibenclamide

Data type

boolean

Alias
UMLS CUI [1]
C0557978
UMLS CUI [2]
C0017628
miconazole therapy
Description

miconazole; therapy

Data type

boolean

Alias
UMLS CUI [1]
C0025942
porphyria
Description

porphyria

Data type

boolean

Alias
UMLS CUI [1]
C3463940
breast feeding
Description

breast feeding

Data type

boolean

Alias
UMLS CUI [1]
C0006147
severe renal failure (creatinine clearance below 30 ml/mn)
Description

creatinine clearance; severe renal failure

Data type

boolean

Alias
UMLS CUI [1]
C0373595
liver failure (prothombine time below 70)
Description

liver failure (prothombine time below 70)

Data type

boolean

Alias
UMLS CUI [1]
C0030605
not affiliated to the health care system
Description

affiliated to the health care system

Data type

boolean

Alias
UMLS CUI [1]
C0029239

Similar models

Eligibility Neonatal Diabetes Secondary to Mutation in the Potassium Channel NCT02375828

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age below 18 years
Item
age below 18 years
boolean
C0001779 (UMLS CUI [1])
Neonatal diabetes mellitus
Item
neonatal diabetes secondary to documented mutation in one of the 2 sub units of potassium channels
boolean
C0158981 (UMLS CUI [1])
glibenclamide; treated by
Item
patients already treated by glibenclamide pills
boolean
C0017628 (UMLS CUI [1])
informed consent
Item
signed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
unable to fill in the questionnaries
Item
families unable to fill in the questionnaries
boolean
C3273494 (UMLS CUI [1,1])
C3714738 (UMLS CUI [1,2])
unable to answer to the visual hedonic squale
Item
patients unable to answer to the visual hedonic squale
boolean
unable to take the oral solution
Item
patients unable to take the oral solution
boolean
C0085732 (UMLS CUI [1,1])
C1720654 (UMLS CUI [1,2])
antibiotic; other; allergy
Item
known allergy to sulfonylureas or to other antidiabetic or antibiotic sulfamides
boolean
C0020517 (UMLS CUI [1,1])
C0038766 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0038703 (UMLS CUI [3,2])
insulin therapy; glibenclamide
Item
insulin therapy associated to glibenclamide
boolean
C0557978 (UMLS CUI [1])
C0017628 (UMLS CUI [2])
miconazole; therapy
Item
miconazole therapy
boolean
C0025942 (UMLS CUI [1])
porphyria
Item
porphyria
boolean
C3463940 (UMLS CUI [1])
breast feeding
Item
breast feeding
boolean
C0006147 (UMLS CUI [1])
creatinine clearance; severe renal failure
Item
severe renal failure (creatinine clearance below 30 ml/mn)
boolean
C0373595 (UMLS CUI [1])
liver failure (prothombine time below 70)
Item
liver failure (prothombine time below 70)
boolean
C0030605 (UMLS CUI [1])
affiliated to the health care system
Item
not affiliated to the health care system
boolean
C0029239 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial